vimarsana.com
Home
Live Updates
Novo Nordisk to buy Cardior Pharma for up to $1 billion : vimarsana.com
Novo Nordisk to buy Cardior Pharma for up to $1 billion : vimarsana.com
Novo Nordisk to buy Cardior Pharma for up to $1 billion
Novo Nordisk A/S bought Cardior Pharmaceuticals for $1 billion to enhance cardiovascular treatments. Cardior's microRNA-targeting therapies aim to improve heart function, aligning with Novo's focus on diabetes and obesity history.
Related Keywords
Denmark ,
Danish ,
Dave Moore ,
Novo Nordisk ,
Cardior Pharmaceuticals ,
Cardior Pharma ,
Weight Loss Drugs ,
Cardiovascular Disease ,
Microrna ,
Wegovy ,
Heart Attacks ,